INGN Inogen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INGN

Price (delayed)

$12.87

Market cap

$295.62M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.67

Enterprise value

$131.88M

Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures, and markets innovative portable oxygen concentrators used to deliver supplemental ...

Highlights
The debt has declined by 13% year-on-year and by 3.6% since the previous quarter
The revenue has increased by 5% year-on-year and by 3.2% since the previous quarter
Inogen's net income has plunged by 67% from the previous quarter
Inogen's EPS has plunged by 66% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.inogen.net
Peers: MASI GTLS RMD ELMD

Key stats

What are the main financial stats of INGN
Market
Shares outstanding
22.97M
Market cap
$295.62M
Enterprise value
$131.88M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.99
Price to sales (P/S)
0.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.35
Earnings
Revenue
$377.24M
EBIT
-$83.27M
EBITDA
-$59.75M
Free cash flow
-$58.75M
Per share
EPS
-$3.67
Free cash flow per share
-$2.57
Book value per share
$12.98
Revenue per share
$16.51
TBVPS
$16.28
Balance sheet
Total assets
$405.04M
Total liabilities
$107.64M
Debt
$23.28M
Equity
$297.41M
Working capital
$239.3M
Liquidity
Debt to equity
0.08
Current ratio
4.66
Quick ratio
3.82
Net debt/EBITDA
2.74
Margins
EBITDA margin
-15.8%
Gross margin
40.7%
Net margin
-22.2%
Operating margin
-22.6%
Efficiency
Return on assets
-18.4%
Return on equity
-24.6%
Return on invested capital
-62.3%
Return on capital employed
-24.5%
Return on sales
-22.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INGN stock price

How has the Inogen stock price performed over time
Intraday
1.66%
1 week
-3.16%
1 month
-45.23%
1 year
-61.34%
YTD
-34.7%
QTD
-34.7%

Financial performance

How have Inogen's revenue and profit performed over time
Revenue
$377.24M
Gross profit
$153.53M
Operating income
-$85.24M
Net income
-$83.77M
Gross margin
40.7%
Net margin
-22.2%
INGN's operating income has dropped by 155% since the previous quarter
The operating margin has plunged by 148% from the previous quarter
Inogen's net income has plunged by 67% from the previous quarter
The net margin has dropped by 62% since the previous quarter

Growth

What is Inogen's growth rate over time

Valuation

What is Inogen stock price valuation
P/E
N/A
P/B
0.99
P/S
0.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.35
Inogen's EPS has plunged by 66% from the previous quarter
INGN's P/B is 80% below its 5-year quarterly average of 4.9 and 42% below its last 4 quarters average of 1.7
The equity has declined by 20% year-on-year and by 15% since the previous quarter
The stock's price to sales (P/S) is 83% less than its 5-year quarterly average of 4.6 and 52% less than its last 4 quarters average of 1.6
The revenue has increased by 5% year-on-year and by 3.2% since the previous quarter

Efficiency

How efficient is Inogen business performance
Inogen's ROS has plunged by 140% from the previous quarter
INGN's ROIC has plunged by 140% from the previous quarter
Inogen's return on equity has shrunk by 77% QoQ
Inogen's ROA has plunged by 75% from the previous quarter

Dividends

What is INGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INGN.

Financial health

How did Inogen financials performed over time
INGN's total assets is down by 17% year-on-year and by 14% since the previous quarter
The company's current ratio fell by 13% YoY and by 3.5% QoQ
The debt is 92% smaller than the equity
The equity has declined by 20% year-on-year and by 15% since the previous quarter
The debt to equity has increased by 14% from the previous quarter and by 14% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.